Company Overview of Hookipa Biotech GmbH
Hookipa Biotech GmbH develops genetic vaccines for the prophylactic and therapeutic treatment of viral diseases. The company’s technology platform, Vaxwave, provides long lasting and potent stimulation of both cellular and humoral immunity. Hookipa Biotech GmbH was founded in 2011 and is based in Vienna, Austria.
Founded in 2011
Key Executives for Hookipa Biotech GmbH
Hookipa Biotech GmbH Key Developments
Similar Private Companies By Industry
|Activartis Biotech GmbH||Europe|
|APEIRON Biologics AG||Europe|
|Apeptico Forschung und Entwicklung GmbH||Europe|
|ARTMA Medical Technologies AG||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Hookipa Biotech GmbH, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.